Sumiyoshi E, Matsuzaki K, Sugimoto N, et al
Furthermore, the potential clinical application of CaPB nano-enzymes in AKI and other RO/NSs-related kidney diseases was highlighted
Simpson SH, Majumdar SR, Tsuyuki RT, et al.: Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study
The medication would be taken as a weekly injection , designed to be self-administered
Semaglutide shows promise for back pain relief, especially in individuals with chronic pain, type 2 diabetes, or obesity